Among the patients with SP–SPM with COVID-19, the laboratory findings indicated a greater incidence of lymphopenia and increased levels of C-reactive protein, urea, and creatinine compared to the non-COVID-19 cases (Supplementary Table S3). This evidence concerns the gene CRP and lymphopenia.